- Home
- EXPI vs SGP Comparison
EXPI vs SGP Comparison
Compare EXPI & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXPI | SGP |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 932.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXPI | SGP |
|---|---|---|
| Price | $5.98 | $25.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $9.75 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.0M | 104.3K |
| Earning Date | 05-05-2026 | 03-26-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,147,681.00 | N/A |
| Revenue This Year | $6.93 | N/A |
| Revenue Next Year | $5.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 220.39 | N/A |
| 52 Week Low | $5.66 | $21.29 |
| 52 Week High | $12.23 | $30.56 |
Technical Indicators
Market Signals| Indicator | EXPI | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 50.17 |
| Support Level | $5.66 | $25.66 |
| Resistance Level | $6.31 | $29.83 |
| Average True Range (ATR) | 0.29 | 1.84 |
| MACD | 0.08 | -0.20 |
| Stochastic Oscillator | 49.26 | 64.69 |
Price Performance
Historical ComparisonAbout EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.